NASDAQ:HARP
Harpoon Therapeutics Inc. Stock Insider Trading
$23.01
+0 (+0%)
At Close: May 02, 2024
| Date | Action | Amount | Person | Type |
|---|---|---|---|---|
| Mar 11, 2024 | Sell | 395 783 | New Leaf Biopharma Opportunities Ii, L.p. | Common Stock |
| Mar 11, 2024 | Sell | 10 000 | New Leaf Biopharma Opportunities Ii, L.p. | 8.000% Series A Redeemable Preferred Stock |
| Mar 11, 2024 | Sell | 299 430 | New Leaf Biopharma Opportunities Ii, L.p. | Common Stock Warrant (Right to Buy) |
| Mar 11, 2024 | Sell | 85 750 | New Leaf Biopharma Opportunities Ii, L.p. | Common Stock Warrant (Right to Buy) |
| Mar 11, 2024 | Sell | 5 000 | Silvernail Lauren P | Common Stock |
| Mar 11, 2024 | Sell | 2 033 | Silvernail Lauren P | Director Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 2 300 | Silvernail Lauren P | Director Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 395 783 | Hunt Ronald | Common Stock |
| Mar 11, 2024 | Sell | 10 000 | Hunt Ronald | 8.000% Series A Redeemable Preferred Stock |
| Mar 11, 2024 | Sell | 299 430 | Hunt Ronald | Common Stock Warrant (Right to Buy) |
| Mar 11, 2024 | Sell | 85 750 | Hunt Ronald | Common Stock Warrant (Right to Buy) |
| Mar 11, 2024 | Sell | 2 033 | Hunt Ronald | Director Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 3 214 | Hunt Ronald | Director Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 2 300 | Hunt Ronald | Director Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 135 000 | Walker Luke Nathaniel | Common Stock |
| Mar 11, 2024 | Sell | 30 500 | Walker Luke Nathaniel | Employee Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 10 000 | Walker Luke Nathaniel | Employee Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 22 665 | Myers Scott Dunseth | Common Stock |
| Mar 11, 2024 | Sell | 2 033 | Myers Scott Dunseth | Director Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 4 600 | Myers Scott Dunseth | Director Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 13 224 | Chin Mark | Common Stock |
| Mar 11, 2024 | Sell | 2 033 | Chin Mark | Director Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 3 214 | Chin Mark | Director Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 2 300 | Chin Mark | Director Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 5 415 | Drachman Jonathan G | Common Stock |
| Mar 11, 2024 | Sell | 5 531 | Drachman Jonathan G | Director Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 1 016 | Drachman Jonathan G | Director Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 2 300 | Drachman Jonathan G | Director Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 5 000 | Robbins Andrew R | Common Stock |
| Mar 11, 2024 | Sell | 1 016 | Robbins Andrew R | Director Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 2 300 | Robbins Andrew R | Director Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 6 499 | Lanza Frank J | Employee Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 18 734 | Lanza Frank J | Common Stock |
| Mar 11, 2024 | Sell | 8 643 | Lanza Frank J | Employee Stock Option (Right to Buy) |
| Mar 11, 2024 | Buy | 31 250 | Eastland Julia Marie | Common Stock |
| Mar 11, 2024 | Sell | 269 381 | Eastland Julia Marie | Common Stock |
| Mar 11, 2024 | Sell | 2 765 | Eastland Julia Marie | Employee Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 40 759 | Eastland Julia Marie | Employee Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 5 000 | Bailes Joseph S | Common Stock |
| Mar 11, 2024 | Sell | 3 142 | Bailes Joseph S | Director Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 2 300 | Bailes Joseph S | Director Stock Option (Right to Buy) |
| Mar 11, 2024 | Sell | 110 000 | Bucher James B | Employee Stock Option (Right to Buy) |
| Mar 11, 2024 | Buy | 21 397 205 | Merck & Co., Inc. | Common Stock, par value $0.0001 |
| Mar 08, 2024 | Buy | 424 | Hunt Ronald | Common Stock |
| Mar 08, 2024 | Buy | 424 | Chin Mark | Common Stock |
| Mar 08, 2024 | Buy | 415 | Drachman Jonathan G | Common Stock |
| Jan 07, 2024 | Buy | 0 | Merck & Co., Inc. | Common Stock, par value $0.0001 |
| Jan 07, 2024 | Buy | 0 | Merck & Co., Inc. | Stock Option (right to buy) |
| Jan 07, 2024 | Buy | 115 000 | Walker Luke Nathaniel | Common Stock |
| Jan 07, 2024 | Buy | 15 000 | Lanza Frank J | Common Stock |
| Jan 07, 2024 | Buy | 178 500 | Eastland Julia Marie | Common Stock |
| Jan 01, 2024 | Buy | 2 048 | Myers Scott Dunseth | Common Stock |
| Jan 01, 2024 | Buy | 1 072 | Hunt Ronald | Common Stock |
| Jan 01, 2024 | Buy | 1 072 | Chin Mark | Common Stock |
| Dec 21, 2023 | Buy | 110 000 | Bucher James B | Employee Stock Option (Right to Buy) |
| Dec 21, 2023 | Buy | 0 | Bucher James B | |
| Nov 27, 2023 | Buy | 5 000 | Silvernail Lauren P | Common Stock |
| Nov 27, 2023 | Buy | 5 000 | Robbins Andrew R | Common Stock |
| Nov 27, 2023 | Buy | 5 000 | Myers Scott Dunseth | Common Stock |
| Nov 27, 2023 | Buy | 5 000 | Hunt Ronald | Common Stock |
| Nov 27, 2023 | Buy | 5 000 | Drachman Jonathan G | Common Stock |
| Nov 27, 2023 | Buy | 5 000 | Chin Mark | Common Stock |
| Nov 27, 2023 | Buy | 5 000 | Bailes Joseph S | Common Stock |
| Nov 26, 2023 | Buy | 20 000 | Walker Luke Nathaniel | Common Stock |
| Nov 26, 2023 | Buy | 2 000 | Lanza Frank J | Common Stock |
| Nov 26, 2023 | Buy | 50 000 | Eastland Julia Marie | Common Stock |
| Oct 25, 2023 | Buy | 1 372 000 | New Leaf Biopharma Opportunities Ii, L.p. | Common Stock |
| Oct 25, 2023 | Buy | 686 000 | New Leaf Biopharma Opportunities Ii, L.p. | Common Stock Warrant (Right to Buy) |
| Oct 25, 2023 | Buy | 171 500 | New Leaf Biopharma Opportunities Ii, L.p. | Common Stock |
| Oct 25, 2023 | Buy | 85 750 | New Leaf Biopharma Opportunities Ii, L.p. | Common Stock Warrant (Right to Buy) |
| Oct 25, 2023 | Buy | 1 372 000 | Hunt Ronald | Common Stock |
| Oct 25, 2023 | Buy | 686 000 | Hunt Ronald | Common Stock Warrant (Right to Buy) |
| Oct 25, 2023 | Buy | 171 500 | Hunt Ronald | Common Stock |
| Oct 25, 2023 | Buy | 85 750 | Hunt Ronald | Common Stock Warrant (Right to Buy) |
| Oct 01, 2023 | Buy | 5 797 | Myers Scott Dunseth | Common Stock |
| Oct 01, 2023 | Buy | 3 035 | Hunt Ronald | Common Stock |
| Oct 01, 2023 | Buy | 3 035 | Chin Mark | Common Stock |
| Jul 01, 2023 | Buy | 18 656 | Chin Mark | Common Stock |
| Jul 01, 2023 | Buy | 18 656 | Hunt Ronald | Common Stock |
| Jul 01, 2023 | Buy | 35 634 | Myers Scott Dunseth | Common Stock |
| Jun 22, 2023 | Buy | 23 000 | Silvernail Lauren P | Director Stock Option (Right to Buy) |
| Jun 22, 2023 | Buy | 23 000 | Robbins Andrew R | Director Stock Option (Right to Buy) |
| Jun 22, 2023 | Buy | 46 000 | Myers Scott Dunseth | Director Stock Option (Right to Buy) |
| Jun 22, 2023 | Buy | 23 000 | Hunt Ronald | Director Stock Option (Right to Buy) |
| Jun 22, 2023 | Buy | 23 000 | Drachman Jonathan G | Director Stock Option (Right to Buy) |
| Jun 22, 2023 | Buy | 23 000 | Chin Mark | Director Stock Option (Right to Buy) |
| Jun 22, 2023 | Buy | 23 000 | Bailes Joseph S | Director Stock Option (Right to Buy) |
| Apr 01, 2023 | Buy | 21 028 | Viney Joanne L. | Common Stock |
| Apr 01, 2023 | Buy | 34 925 | Myers Scott Dunseth | Common Stock |
| Apr 01, 2023 | Buy | 18 285 | Hunt Ronald | Common Stock |
| Apr 01, 2023 | Buy | 16 456 | Colowick Alan | Common Stock |
| Apr 01, 2023 | Buy | 18 285 | Chin Mark | Common Stock |
| Mar 23, 2023 | Buy | 0 | New Leaf Biopharma Opportunities Ii, L.p. | Common Stock |
| Mar 23, 2023 | Buy | 0 | New Leaf Biopharma Opportunities Ii, L.p. | Common Stock |
| Mar 23, 2023 | Buy | 0 | New Leaf Biopharma Opportunities Ii, L.p. | 8.000% Series A Redeemable Preferred Stock |
| Mar 23, 2023 | Buy | 2 994 305 | New Leaf Biopharma Opportunities Ii, L.p. | Common Stock Warrant (Right to Buy) |
| Mar 23, 2023 | Buy | 2 994 305 | Hunt Ronald | Common Stock Warrant (Right to Buy) |
| Mar 23, 2023 | Buy | 10 000 | Hunt Ronald | 8.000% Series A Redeemable Preferred Stock |
| Jan 24, 2023 | Buy | 65 000 | Lanza Frank J | Employee Stock Option (right to buy) |
| Jan 24, 2023 | Buy | 100 000 | Walker Luke Nathaniel | Employee Stock Option (right to buy) |
| INSIDER POWER |
|---|
| 79.079 |
| Last 100 transactions |
| Buy: 33 131 312 | Sell: 2 314 176 (Shares) |
Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 79.079.
In total, the insiders bought 33 131 312 and sold 2 314 176 HARP shares in the last 100 trades.
